RESULTS: Before treatment, there were significant differences in the BMD of L2-4 and femoral neck, osteocalcin, TPINP and VAS scores between 2 groups (P>0.05).
结果：治疗前，两组患者L2～4和股骨颈的BMD、骨钙素、TPINP、VAS评分比较，差异均无统计学意义（P＞0.05）。
The patients from 5 DMD and 2 BMD were detected by immunofluorescence technique for analyzing dystrophin located in muscle cell membrane, compared with 2 normal males.
并采用免疫荧光抗体染色技术对5例dmd,2例BMD肌细胞膜上抗肌营养不良蛋白的表达观察分析，以2例正常人的肌组织作为对照。
Conclusion BMD of elder male type 2 diabetic patients were affected by varied factors, especially by gradually deteriorating diabetic nephropathy.
结论老年男性2型糖尿病患者的骨密度与多种因素有关，糖尿病肾病的进展是其重要的影响因素。
Methods: Height, weight, fasting serum C-peptide, IGF-2, and BMD were measure in 96 patients with DM.
方法：96例2型糖尿病患者，均测量身高、体质量、骨密度、骨密度以及空腹血清C肽和IGF - 2水平。
Lumbar spine 3-5 and distal 1/2 part of the right and left femur bone mineral density(BMD) were measured before OVX, implantation and sacrifice.
去势术前、种植术前及处死前分别测量大鼠腰椎3-5、左右股骨远中1/2骨密度。
OBJECTIVE:To investigate the correlations between serum osteoprotegerin (OPG) levels and bone mineral density (BMD) in postmenopausal women with type 2 diabetes(T2DM).
目的：研究绝经后女性2型糖尿病（T2DM）患者血清护骨素（OPG）水平与骨密度（BMD）的关系。
Objective: To study the changes of bone mineral density (BMD) in female patients with type 2 diabetes.
目的研究女性糖尿病患者骨密度的变化。
Objective: To study the changes of bone mineral density (BMD) in female patients with type 2 diabetes.
目的研究女性糖尿病患者骨密度的变化。
应用推荐